Ranchi, March 22 (IANS) Another Jharkhand Mukti Morcha (JMM) legislator contesting the Lok Sabha polls has resigned from the assembly, said an official Saturday.
The official told IANS that Vidyut Baran Mahto is fighting for the Jamshedpur seat on a BJP ticket.
Mahto is the second JMM legislator to quit after Hemlal Murmu resigned Friday.
The resignations follow Speaker Shashak Shekhar Bhokta's notice to two JMM legislators who were fielded by the Bharatiya Janata Party as nominees in Lok Sabha polls.
Both Mumrmu and Mahto have joined the BJP and are party candidates for the Rajmahal and Jamsahedpur Lok Sabha seat respectively.
Chandra Shekhar Dubey, who is Trinamool Congress candidate from Dhanbad and has resigned from the Congress, Thursday also quit membership of the Jharkhand assembly.
After the exit of three, the strength of the assembly has been reduced from 82 to 79.
new Delhi. Research from many reputed institutions of the world has shown that where air pollutio
The National Anti-Profiteering Authority (NAA) has found L'Oreal India and India Bulls Real Estat
After the crushing defeat in Australia, the Board of Control for Cricket in India (BCCI) has now
India, US moving towards civil n-deal: Obama
New Delhi, Jan 25 (IANS) We have achieved a breakthrough and are moving towards full implementa
A day before the digital release of 'Amar Singh Chamkila', its makers organized a special screeni
Moderna claims - the effect of the corona vaccine decreases with time, a booster dose is needed
The war against the corona epidemic continues across the world. A vaccine is considered to be the
The country is celebrating the birthday of Prime Minister Narendra Modi today. Various programs a
India, US close to implementation of civil nuclear deal
New Delhi, March 20 (IANS) India and the US are on way to implementation of their long-pending
The war between Russia and Ukraine continues for the 34th day. The Russian army is constantly fir
Which country will have Covid's first vaccine?
Worldwide, there is a competition to prepare the coronavirus vaccine and the most talked about is